The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming

Journal of Experimental Medicine

Volumn 187, Issue 11, 1998, Pages 1799-1811

  Antalis, Toni M ^a,b   Linn, May La ^a   Donnan, Karen ^a   Mateo, Luis ^a   Gardner, Joy ^a   Dickinson, Joanne L ^a   Buttigieg, Kathy ^a   Suhrbier, Andreas ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Alphavirus; Interferon; Plasminogen activator inhibitor; Ross River virus; Serpin

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; PLASMINOGEN ACTIVATOR INHIBITOR; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL INVASION; CELL PROTECTION; CELL SURVIVAL; CYTOPATHOGENIC EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GLYCOSYLATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY; VIRUS INFECTION;

ADENOVIRUSES, HUMAN; ALPHAVIRUS; ANTIVIRAL AGENTS; APOPTOSIS; CYTOPATHOGENIC EFFECT, VIRAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INFLUENZA A VIRUS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; PLASMINOGEN ACTIVATOR INHIBITOR 2; POLY I-C; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; ROSS RIVER VIRUS; SERINE PROTEINASE INHIBITORS; SINDBIS VIRUS; TRANSCRIPTION FACTORS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 0032101523     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.11.1799     Document Type: Article

References (61)

1. Remold-O'Donnell, E. 1993. The ovalbumin family of serpin proteins. FEBS Lett. 315:105-108.
2. Ray, C.A., R.A. Black, S.R. Kronheim, T.A. Greenstreet, P.R. Sleath, G.S. Salvesen, and D.J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69:597-604.
3. Antalis, T.M., M.A. Clark, T. Barnes, P.R. Lehrbach, P.L. Devine. G. Schevzov, N.H. Goss, R.W. Stephens, and P. Tolstoshev. 1988. Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA. 85:985-989.
4. Zou, Z., A. Anisowicz, M.J.C. Hendrix, A. Thor, M. Neveu, S. Sheng, K. Rafidi, E. Seftor, and R. Sager. 1994. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 263:526-529.
5. Scott, F.L., P.B. Coughlin, C. Bird, L. Cerruti, J.A. Hayman, and P. Bird. 1996. Protease inhibitor 6 cannot be secreted, which suggests it's a new type of cellular serpin. J. Biol. Chem. 271:1605-1612.
6. Sun, J., C.H. Bird, V. Sutton, L. McDonald, P.B. Coughlin, T.A. DeJong, J.A. Trapani, and P.I. Bird. 1996. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Bol. Chem. 271:27802-27809.
7. Zhou, Q., S. Snipas, K. Orth, M. Muzio, V.M. Dixit, and G.S. Salvesen. 1997. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272: 7797-7800.
8. Kettle, S., A. Alcami, A. Khanna, R. Ehret, C. Jassoy, and G.L. Smith. 1997. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β-converting enzyme and protects virus-infected cells from TNF-and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever. J. Gen. Virol. 78:677-685.
9. Kruithof, E.K.O., M.S. Baker, and C.L. Bunn. 1995. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood. 86:4007-4024.
10. Von Heijne, G., P. Liljestrom, P. Mikus, H. Andersson, and T. Ny. 1991. The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity. J. Biol. Chem. 266:15240-15246.
11. Kumar, S., and C. Baglioni. 1991. Protection from tumour necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266: 20960-20964.
12. Dickinson, J.L., E.J. Bates, A. Ferrante, and T.M. Antalis. 1995. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem. 270:27894-27904.
13. Gan, H., G.W. Newman, and H.G. Remold. 1995. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J. Immunol. 155:1304-1315.
14. Strauss, J.H., and E.G. Strauss. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58: 491-562.
15. Ziegler-Heitbrock, H.W.L., E. Thiel, A. Fuetterer, V. Herzog, A. Wirtz and U. Riethmueller. 1988. Establishment of a human cell line (MonoMac6) with characteristics of mature monocytes. Int. J. Cancer. 41:456-461.
16. Linn, M.L., J. Aaskov and A. Suhrbier. 1996. Antibody dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J. Gen. Virol. 77:407-412.
17. Piper, R.C., J.W. Slot, G. Li., P.D. Stahl, and D.E. James. 1994. Recombinant Sindbis virus as an expression system for cell biology. Methods Cell. Biol. 43:55-78.
18. Parsons, P.G., J. Lean, S.K. Khoo, and J. Lark. 1989. Effects of adriamycin and etoposide on the replication of adenovirus 5 in sensitive and resistant human tumour cells. Biochem. Pharmacol. 38:31-37.
19. Boyle, D.B., B.E. Coupar, and G.W. Both. 1985. Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses. Gene. 35:169-177.
20. Antalis, T.M., and D. Godbolt. 1991. Isolation of intact nuclei from hematopoietic cell types. Nucleic Acids Res. 19:4301.
21. Kalvakolanu, D.V., and E.C. Borden. 1996. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 14:25-53.
22. Demczuk, S., M. Harbers, and B. Vennström. 1993. Identification and analysis of all components of a gel retardation assay by combination with immunoblotting. Proc. Natl. Acad. Sci. USA. 90:2574-2578.
23. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M.T. Fernandez-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Marti, D. Jaraquemada, and R. Pujol-Borrell. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153:1360-1377.
24. Merlin, G., J. Chebath, P. Benech, R. Metz, and M. Revel. 1983. Molecular cloning and sequence of partial cDNA for interferon-induced (2′-5′) oligo(A) synthetase mRNA from human cells. Proc. Natl. Acad. Sci. USA. 80:4904-4908.
25. Levine, B., Q. Huang, J.T. Isaacs, J.C. Reed, D.E. Griffin, and J.M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature. 361:739-742.
26. Chiou, S.K., C.C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19-kilo-dalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
27. Takizawa, T., S. Matsukawa, Y. Higuchi, S. Nakamura, Y. Nakanishi, and R. Fukuda. 1993. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74:2347-2355.
28. Ink, B.S., C.S. Gilbert, and G.I. Evan. 1995. Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes. J. Virol. 69:661-668.
29. Martin, J.H., R.C. Weir, and L. Dalgarno. 1979. Replication of standard and defective Ross River virus in BHK cells: patterns of viral RNA and polypeptide synthesis. Arch. Virol. 61: 87-103.
30. Lin, K.I., S.H. Lee, R. Narayanan, J.M. Baraban, J.M. Hardwick, and R.R. Ratan. 1995. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J. Cell Biol. 131: 1149-1161.
31. Jensen, P.H., L.I. Cressey, B.T. Gjertsen, P. Madsen, G. Mellgren, P. Hokland, J. Gliemann, S.O. Doskeland, M. Lanotte, and O.K. Vintermyr. 1994. Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br. J. Cancer. 70:834-840.
32. Munoz, A., and L. Carrasco. 1984. Action of human lymphoblastoid interferon on HeLa cells infected with RNA-containing animal viruses. J. Gen. Virol. 65:377-390.
33. Beattie, E., K.L. Denzler, J. Tartaglia, M.E. Perkus, E. Paoletti, and B.L. Jacobs. 1995. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
34. Friedman, R.M., and J.M. Ramseur. 1979. Mechanisms of persistent infections by cytopathic viruses in tissue culture. Arch. Virol. 60:83-103.
35. King, P, and S. Goodbourn. 1994. The beta-interferon promoter responds to priming through multiple independent regulatory elements. J. Biol. Chem. 269:30609-30615.
36. Bandyopadhyay, S.K., and G.C. Sen. 1992. Role of protein phosphorylation in activation of interteron-stimulated gene factors. J. Biol. Chem. 267:6389-6395.
37. Bandyopadhyay, S.K., D.V.R. Kalvakolanu, and G.C. Sen. 1990. Gene induction by interferons: functional complementation between trans-acting factors induced by alpha interferon and gamma interferon. Mol. Cell. Biol. 10:5055-5063.
38. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Sato, K. Ozato, and T. Fujita. 1996. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120:160-169.
39. Yang, Y.L., L.F. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B.R. Williams, M. Aguet, and C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO (Eur. Mol. Biol. Organ.) J. 14:6095-6106.
40. Chen, L. 1985. Cell to cell transmission of the "priming" effect on the induction of human fibroblast interferon. J. Interferon Res. 5:111-119.
41. Schwartz, B.S., and J.D. Bradshaw. 1992. Regulation of plasminogen activation inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein. J. Biol. Chem. 267:7089-7094.
42. Antalis, T.M., and J.L. Dickinson. 1992. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Eur. J. Biochem. 205:203-209.
43. Schleuning, W.D., R.L. Metcalf, C. Hession, R. Rothenbuehler, A. Shaw, and E.K.O. Kruithof. 1987. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol. Cell. Biol. 7:4564-4567.
44. Yeung, M.C., J. Liu, and A.S. Lau. 1996. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. USA. 93:12451-12455.
45. Ruby, J., H. Bluethmann, and J.J. Peschon. 1997. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J. Exp. Med. 186:1591-1596.
46. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type-1 IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
47. Au, W.C., P.A. Moore, W. Lowther, Y.T. Juang, and P.M. Pitha. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA. 92:11657-11661.
48. Daly, C., and N.C. Reich. 1995. Characterisation of specific DNA-binding factors activated by double stranded RNA as positive regulators of interferon α/β-stimulated genes. J. Biol. Chem. 270:23739-23746.
49. Bandyopadhyay, S.K., G.T. Leonard, T. Bandyopadhyay, G.R. Stark, and G.C. Sen. 1995. Transcriptional induction by double stranded RNA is mediated by interferon-stimulated gene factor 3. J. Biol. Chem. 270:19624-19629.
50. Pine, R. 1992. Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J. Virol. 66:4470-4478.
51. Meldrum, D.R., J.C. Cleveland, Jr., E.E. Moore, D.A. Patrick, A. Banerjee, A.H. Harken. 1997. Adaptive and maladaptive mechanisms of cellular priming. Ann. Surg. 226: 587-598.
52. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:787-789.
53. Whiteside, S.T., P. King, and S. Goodboum. 1994. A truncated form of the IRF-2 transcription factor has the properties of a postinduction repressor of interteron-beta gene expression. J. Biol. Chem. 269:27059-27065.
54. Krishnamurti, C., L.M. Wahl, and B.M. Alving. 1989. Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus. Am. J. Trop. Med. Hyg. 40:102-107.
55. Metcalf, R.L., E.K.O. Kruithof, and W.-D. Schleuning. 1988. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J. Exp. Med. 168: 751-759.
56. Antalis, T.M., D. Godbolt, K.D. Donnan, and B.W. Stringer. 1993. Southwestern blot mapping of potential regulatory-proteins binding to the DNA encoding plasminogen activator inhibitor type 2. Gene. 134:201-208.
57. Li, X.X., S. Leung, S. Qureshi, J.E. Darnell, and G.R. Stark. 1996. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon alpha. J. Biol. Chem. 271:5790-5794.
58. Jensen, P.J., Q. Wu, P. Janowitz, Y. Ando, and N.M. Schlechter. 1995. Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp. Cell Res. 217:65-71.
59. Yaar, M., A.V. Palleroni, and B.A. Gilchrest. 1986. Normal human epidermis contains an interferon-like protein. J. Cell Biol. 103:1349-1354.
60. Cumberbatch, M., and I. Kimber. 1995. Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 84:31-35.
61. Angelici, E., C. Contini, R. Romani, O. Epifano, P. Serra, and R. Campari. 1996. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients. AIDS. 10:283-290.